COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms Robert W. Malone (
[email protected] ) RW Malone MD LLC, Madison, VA https://orcid.org/0000-0003-0340-7490 Philip Tisdall Medical School Companion LLC, Marco Island, FL Philip Fremont-Smith MIT Lincoln Laboratory, Lexington, MA Yongfeng Liu Department of Pharmacology, University of North Carolina, Chapel Hill, Chapel Hill, NC Xi-Ping Huang Department of Pharmacology, University of North Carolina, Chapel Hill, Chapel Hill, NC Kris M. White Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY Lisa Miorin Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY Elena Moreno Del Olmo Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY Assaf Alon Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA Elise Delaforge McGill University, Department of Chemistry, Montreal, Quebec, Canada Christopher D. Hennecker McGill University, Department of Chemistry, Montreal, Quebec, Canada Guanyu Wang McGill University, Department of Chemistry, Montreal, Quebec, Canada Joshua Pottel Molecular Forecaster Inc, Montreal, Quebec, Canada Robert Bona Frank H. Netter MD School of Medicine – Quinnipiac University, Hamden, CT Nora Smith MIT Lincoln Laboratory, Lexington, MA Page 1/35 Julie M. Hall Frank H. Netter MD School of Medicine – Quinnipiac University, Hamden, CT Gideon Shapiro Pharmorx LLC, Gainesville, FL Howard Clark University College London, London, UK Anthony Mittermaier McGill University, Department of Chemistry, Montreal, Quebec, Canada Andrew C. Kruse Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA Adolfo García-Sastre Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY Bryan L.